Cost-effectiveness analysis of thermotherapy versus pentavalent antimonials for the treatment of cutaneous leishmaniasis. (Q50677795)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28276641 AND SRC:MED&resulttype=core&format=json

5 April 2020

title

Cost-effectiveness analysis of thermotherapy versus pentavalent antimonials for the treatment of cutaneous leishmaniasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28276641 AND SRC:MED&resulttype=core&format=json

Jaiberth Antonio Cardona-Arias

5 April 2020

author

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28276641 AND SRC:MED&resulttype=core&format=json

5 April 2020

author name string

Liliana López-Carvajal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28276641 AND SRC:MED&resulttype=core&format=json

5 April 2020

Mery Patricia Tamayo Plata

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28276641 AND SRC:MED&resulttype=core&format=json

5 April 2020

Iván Darío Vélez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28276641 AND SRC:MED&resulttype=core&format=json

5 April 2020

publication date

1 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28276641 AND SRC:MED&resulttype=core&format=json

Journal of Evidence-Based Medicine

5 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28276641 AND SRC:MED&resulttype=core&format=json

5 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28276641 AND SRC:MED&resulttype=core&format=json

5 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28276641 AND SRC:MED&resulttype=core&format=json

5 April 2020

page(s)

81-90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28276641 AND SRC:MED&resulttype=core&format=json

Leishmaniasis worldwide and global estimates of its incidence

5 April 2020

cites work

1 reference

Leishmaniasis: current situation and new perspectives

21 January 2018

1 reference

Cost-effectiveness of prevention strategies for American tegumentary leishmaniasis in Argentina

21 January 2018

1 reference

Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis

21 January 2018

1 reference

Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.

21 January 2018

1 reference

Treatment of New World cutaneous and mucosal leishmaniases

21 January 2018

1 reference

Leishmaniasis: current treatment and prospects for new drugs and vaccines

21 January 2018

1 reference

Advances in leishmaniasis

21 January 2018

1 reference

Leishmaniasis: drugs in the clinic, resistance and new developments.

21 January 2018

1 reference

Current treatment for cutaneous leishmaniasis: a review

21 January 2018

1 reference

The evaluation of the tolerance and nephrotoxicity of pentavalent antimony administered in a dose of 40 mg Sb V/kg/day, 12/12 hr, for 30 days in the mucocutaneous form of leishmaniasis

21 January 2018

1 reference

Out-patient parenteral antimicrobial therapy--a viable option for the management of cutaneous leishmaniasis

21 January 2018

1 reference

The traditional and conventional medical treatment of cutaneous leishmaniasis in rural Ecuador

21 January 2018

1 reference

Efficacy of thermotherapy to treat cutaneous leishmaniasis: a meta-analysis of controlled clinical trials.

21 January 2018

1 reference

Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations

21 January 2018

1 reference

Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs

21 January 2018

1 reference

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent

21 January 2018

1 reference

Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India

21 January 2018

1 reference

Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting

21 January 2018

1 reference

Drug policy for visceral leishmaniasis: a cost-effectiveness analysis

21 January 2018

1 reference

The economic value of a visceral leishmaniasis vaccine in Bihar state, India

21 January 2018

1 reference

The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas

21 January 2018

1 reference

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

21 January 2018

1 reference

Evaluation of Thermotherapy for the Treatment of Cutaneous Leishmaniasis in Kabul, Afghanistan: A Randomized Controlled Trial

21 January 2018

1 reference

Thermotherapy effective and safer than miltefosine in the treatment of cutaneous leishmaniasis in Colombia

21 January 2018

1 reference

Short communication: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004.

21 January 2018

1 reference

Efficacy of cryotherapy for the treatment of cutaneous leishmaniasis: meta-analyses of clinical trials.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JEBM.12245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28276641 AND SRC:MED&resulttype=core&format=json

5 April 2020

1 reference